The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis

Current Allergy and Asthma Reports

Volumn 5, Issue 2, 2005, Pages 130-135

  Brightling, Christopher E ^a   Bradding, Peter ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CHEMOKINE RECEPTOR CXCR3; CROMOGLYCATE DISODIUM; CYTOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTAMINE; INTERLEUKIN 8; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL SODIUM; SALBUTAMOL; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHITIS; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CELL FUNCTION; CELL INTERACTION; CLINICAL TRIAL; COUGHING; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; IMMUNOPATHOLOGY; MAST CELL; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 14744295367     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0086-9     Document Type: Review

References (47)

1. Wardlaw AJ, Brightling C, Green R, et al.: Eosinophils in asthma and other allergic diseases. Br Med Bull 2000, 56:985-1003.
2. Robinson DS, Hamid Q, Ying S, et al.: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
3. Djukanovic R, Wilson JW, Britten KM, et al.: Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990, 142:863-871.
4. Leckie MJ, ten Brinke A, Khan J, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000, 356:2144-8.
5. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003, 167:199-204.
6. Green RH, Brightling CE, Woltmann GW, et al.: Analysis of induced sputum in adults with asthma: identification of a subgroup with neutrophilic inhaled corticosteroid resistant disease. Thorax 2002, 57:875-879.
7. Brightling CE, Ward P, Goh KL, et al.: Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999, 160:406-410.
8. Gibson PG, Dolovich J, Denburg J, et al.: Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989, 1:1346-1348.
9. Brightling CE, Bradding P, Symon FA, et al.: Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002, 346:1699-1705.
10. Schwartz LB, Irani AM, Roller K, et al.: Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 1987, 138:2611-2615.
11. MacGlashan DW Jr, Schleimer RP, Peters SP, et al.: Generation of leukotrienes by purified human lung mast cells. J Clin Invest 1982, 70:747-751.
12. Bradding P, Roberts JA, Britten KM, et al.: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994, 10:471-480.
13. Machado DC, Horton D, Harrop R, et al.: Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 1996, 26:2972-2980.
14. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL: Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983, 157: 981-1991.
15. Banks JR, Kagey-Sobotka A, Lichtenstein LM, Eggleston PA: Spontaneous histamine release after exposure to hyperosmolar solutions. J Allergy Clin Immunol 1986, 78:51-57.
16. Liu MC, Bleecker ER, Lichtenstein LM, et al.: Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990, 142:126-132.
17. Sedgwick JB, Calhoun WJ, Cleich GJ, et al.: Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991, 144:1274-1281.
18. Church MK, Hiroi J: Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987, 90:421-429.
19. Howarth PH, Durham SR, Lee TH, et al.: Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 1985, 132:986-992.
20. Roquet A, Dahlen B, Kumlin M, et al.: Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997, 155:1856-1863.
21. Carroll NG, Mutavdzic S, James AL: Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002, 19:879-885.
22. Pesci A, Foresi A, Bertorelli G, et al.: Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 1993, 147:684-689.
23. Gibson PG, Allen CJ, Yang JP, et al.: Intraepithelial mast cells in allergic and nonallergic asthma: assessment using bronchial brushings. Am Rev Respir Dis 1993, 148: 0-86.
24. Connell JT: Asthmatic deaths: role of the mast cell. JAMA 1971, 215:769-776.
25. Carroll NG, Mutavdzic S, James AL: Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002, 57:677-682.
26. Koshino T, Teshima S, Fukushima N, et al.: Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993, 23: 19-925.
27. Ammit AJ, Bekir SS, Johnson PR, et al.: Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med 1997, 155:1123-1129.
28. Broide DH, Gleich GJ, Cuomo AJ, et al.: Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991, 88:637-648.
29. Casale TB, Wood D, Richerson HB: Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987, 79:1197-1203.
30. Wardlaw AJ, Dunnette S, Gleich GJ, et al.: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988, 137:62-69.
31. Brightling CE, Symon FA, Holgate ST, et al.: Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy 2003, 33: 711-1716.
32. Swystun VA, Gordon JR, Davis EB, et al.: Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000, 106: 7-64.
33. Djukanovic R, Wilson JW, Britten KM, et al.: Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992, 145:669-674.
34. Djukanovic R, Wilson SJ, Kraft M, et al.: Effects of treatment with anti-immunoglobulin e antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004, 170:583-593.
35. Milgrom H, Fick RB, Su JQ, et al.: Treatment of allergic asthma with monoclonal anti-IgE antibody. N Eng J Med 1999, 342:1966-1973.
36. Busse WW, Corren J, Lanier BQ, et al.: Omalizumab, anti-IgE recombinant humanised monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001, 108: 84-190.
37. Boulet LP, Chapman KR, Cote J, et al.: Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997, 155:1835-1840.
38. Berger P, Girodet PO, Begueret H, et al.: Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J 2003, 17: 139-2141.
39. Hirst SJ, Hallsworth MP, Peng Q, Lee TH: Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med 2002, 165:1161-1171.
40. John M, Au BT, Jose PJ, et al.: Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 1998, 18:84-90.
41. Brightling CE, Ammitt AJ, Berger P, et al.: CXCL10 (IP-10) is a novel mast cell chemokine and is released by asthmatic airway smooth muscle. Am J Respir Crit Care Med 2004, 169: 569.
42. Broekelmann TJ, Limper AH, Colby TV, et al.: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci 1991, 88:6642-6646.
43. Brown JK, Jones CA, Rooney LA, et al.: Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am J Physiol Lung Cell Mol Physiol 2002, 282:L197-L206.
44. Panettieri RA, Tan EM, Ciocca V, et al.: Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. J Respir Cell Mol Biol 1998, 19:453-461.
45. Rajah R, Nunn SE, Herrick DJ, et al.: Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am J Physiol 1996, 271:L1014-L1022.
46. Laporte JC, Moore PE, Baraldo S, et al.: Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001, 164:141-148.
47. Grunstein MM, Hakonarson H, Leiter J, et al.: IL-13 dependent autocrine signalling mediates altered responsiveness of IgE-sensitized airway smooth muscle: Am J Physiol Lung Cell Mol Physiol 2002, 282:520-528.